Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Analysis of fragment ends in plasma DNA from patients with cancer

Karan K. Budhraja, Bradon R. McDonald, Michelle D. Stephens, Tania Contente-Cuomo, Havell Markus, Maria Farooq, Patricia F. Favaro, Sydney Connor, Sara A. Byron, Jan B. Egan, Brenda Ernst, Timothy K. McDaniel, Aleksandar Sekulic, Nhan L. Tran, Michael D. Prados, Mitesh J. Borad, View ORCID ProfileMichael E. Berens, Barbara A. Pockaj, Patricia M. LoRusso, Alan Bryce, Jeffrey M. Trent, View ORCID ProfileMuhammed Murtaza
doi: https://doi.org/10.1101/2021.04.23.21255935
Karan K. Budhraja
1Department of Surgery and Center for Human Genomics and Precision Medicine, University of Wisconsin-Madison; Madison, WI 53705, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bradon R. McDonald
1Department of Surgery and Center for Human Genomics and Precision Medicine, University of Wisconsin-Madison; Madison, WI 53705, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michelle D. Stephens
1Department of Surgery and Center for Human Genomics and Precision Medicine, University of Wisconsin-Madison; Madison, WI 53705, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tania Contente-Cuomo
2Translational Genomics Research Institute, Phoenix, AZ 85004, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Havell Markus
3Pennsylvania State University, Hershey, PA 17033, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria Farooq
4Department of Medicine, The University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patricia F. Favaro
1Department of Surgery and Center for Human Genomics and Precision Medicine, University of Wisconsin-Madison; Madison, WI 53705, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sydney Connor
5Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD, 21218 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sara A. Byron
2Translational Genomics Research Institute, Phoenix, AZ 85004, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jan B. Egan
6Mayo Clinic, Scottsdale, AZ 85259, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brenda Ernst
6Mayo Clinic, Scottsdale, AZ 85259, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Timothy K. McDaniel
2Translational Genomics Research Institute, Phoenix, AZ 85004, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aleksandar Sekulic
6Mayo Clinic, Scottsdale, AZ 85259, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nhan L. Tran
6Mayo Clinic, Scottsdale, AZ 85259, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael D. Prados
7Department of Neurological Surgery, University of California, San Francisco, San Francisco, California, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mitesh J. Borad
6Mayo Clinic, Scottsdale, AZ 85259, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael E. Berens
2Translational Genomics Research Institute, Phoenix, AZ 85004, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Michael E. Berens
Barbara A. Pockaj
6Mayo Clinic, Scottsdale, AZ 85259, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patricia M. LoRusso
8Yale Cancer Center, New Haven, CT 06520, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alan Bryce
6Mayo Clinic, Scottsdale, AZ 85259, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeffrey M. Trent
2Translational Genomics Research Institute, Phoenix, AZ 85004, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Muhammed Murtaza
1Department of Surgery and Center for Human Genomics and Precision Medicine, University of Wisconsin-Madison; Madison, WI 53705, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Muhammed Murtaza
  • For correspondence: murtaza@surgery.wisc.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Fragmentation patterns observed in plasma DNA reflect chromatin accessibility in contributing cells. Since DNA shed from cancer cells and blood cells may differ in fragmentation patterns, we investigated whether analysis of genomic positioning and nucleotide sequence at fragment ends can reveal the presence of tumor DNA in blood and aid cancer diagnostics. We analyzed whole genome sequencing data from >2700 plasma DNA samples including healthy individuals and patients with 11 different cancer types. We observed higher fractions of fragments with aberrantly positioned ends in patients with cancer, driven by contribution of tumor DNA into plasma. Genomewide analysis of fragment ends using machine learning showed overall area under the receiver operative characteristic curve of 0.96 for detection of cancer. Our findings remained robust with as few as 1 million fragments analyzed per sample, suggesting that analysis of fragment ends can become a cost-effective and accessible approach for cancer detection and monitoring.

One-sentence summary Analyzing the positioning and nucleotide sequence at fragment ends in plasma DNA may enable cancer diagnostics.

Competing Interest Statement

BRM, HM and MM are inventors on patent applications covering technologies described here including patent application number PCT/US20/41469, titled 'Methods of detecting disease and treatment response in cfDNA'. MM consults for AstraZeneca and Bristol Myers Squibb, and serves on the scientific advisory board of PetDx. BRM, TCC and MM have licensing relationships with Exact Sciences. All other authors declare that they have no competing interests.

Funding Statement

Supported by funding from the Ben and Catherine Ivy Foundation to MM, JMT and SC, from the National Cancer Institute (NCI) of the National Institutes of Health (NIH) under award number 1U01CA243078-01A1 to MM and 1R01CA223481-01 to MM, and by a Stand Up To Cancer (SU2C) - Melanoma Research Alliance Melanoma Dream Team Translational Cancer Research Grant (#SU2C-AACR-DT0612) to JMT and PML. Stand Up To Cancer is a program of the Entertainment Industry Foundation administered by the American Association for Cancer Research (AACR).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Healthy volunteers were enrolled at the Translational Genomics Research Institute in Phoenix, AZ and blood samples were collected under protocol numbers 20142638, and 20181812, approved by Western Institutional Review Board (IRB). Blood and tissue samples from patients with melanoma were collected at Mayo Clinic in Scottsdale, AZ under protocol number 16-001453 and within a multi-center clinical trial (NCT02094872) under protocol number 20140190 approved by Western IRB. Blood samples from patients with breast cancer were collected at Mayo Clinic in Scottsdale, AZ under protocol number 14-006021, from patients with glioblastoma within a clinical trial (NCT02060890) at University of California in San Francisco, CA under protocol number 20141201 approved by Western IRB, and from patients with cholangiocarcinoma at Mayo Clinic in Scottsdale, AZ under protocol number 12-004713.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Plasma sequencing data generated for this study will be deposited in dbGaP once the manuscript is accepted for publication.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted April 27, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Analysis of fragment ends in plasma DNA from patients with cancer
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Analysis of fragment ends in plasma DNA from patients with cancer
Karan K. Budhraja, Bradon R. McDonald, Michelle D. Stephens, Tania Contente-Cuomo, Havell Markus, Maria Farooq, Patricia F. Favaro, Sydney Connor, Sara A. Byron, Jan B. Egan, Brenda Ernst, Timothy K. McDaniel, Aleksandar Sekulic, Nhan L. Tran, Michael D. Prados, Mitesh J. Borad, Michael E. Berens, Barbara A. Pockaj, Patricia M. LoRusso, Alan Bryce, Jeffrey M. Trent, Muhammed Murtaza
medRxiv 2021.04.23.21255935; doi: https://doi.org/10.1101/2021.04.23.21255935
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Analysis of fragment ends in plasma DNA from patients with cancer
Karan K. Budhraja, Bradon R. McDonald, Michelle D. Stephens, Tania Contente-Cuomo, Havell Markus, Maria Farooq, Patricia F. Favaro, Sydney Connor, Sara A. Byron, Jan B. Egan, Brenda Ernst, Timothy K. McDaniel, Aleksandar Sekulic, Nhan L. Tran, Michael D. Prados, Mitesh J. Borad, Michael E. Berens, Barbara A. Pockaj, Patricia M. LoRusso, Alan Bryce, Jeffrey M. Trent, Muhammed Murtaza
medRxiv 2021.04.23.21255935; doi: https://doi.org/10.1101/2021.04.23.21255935

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Genetic and Genomic Medicine
Subject Areas
All Articles
  • Addiction Medicine (215)
  • Allergy and Immunology (495)
  • Anesthesia (106)
  • Cardiovascular Medicine (1093)
  • Dentistry and Oral Medicine (195)
  • Dermatology (141)
  • Emergency Medicine (274)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (499)
  • Epidemiology (9757)
  • Forensic Medicine (5)
  • Gastroenterology (480)
  • Genetic and Genomic Medicine (2303)
  • Geriatric Medicine (222)
  • Health Economics (462)
  • Health Informatics (1553)
  • Health Policy (732)
  • Health Systems and Quality Improvement (602)
  • Hematology (236)
  • HIV/AIDS (501)
  • Infectious Diseases (except HIV/AIDS) (11631)
  • Intensive Care and Critical Care Medicine (616)
  • Medical Education (236)
  • Medical Ethics (67)
  • Nephrology (256)
  • Neurology (2139)
  • Nursing (134)
  • Nutrition (335)
  • Obstetrics and Gynecology (426)
  • Occupational and Environmental Health (517)
  • Oncology (1172)
  • Ophthalmology (363)
  • Orthopedics (128)
  • Otolaryngology (220)
  • Pain Medicine (145)
  • Palliative Medicine (50)
  • Pathology (309)
  • Pediatrics (694)
  • Pharmacology and Therapeutics (298)
  • Primary Care Research (265)
  • Psychiatry and Clinical Psychology (2172)
  • Public and Global Health (4645)
  • Radiology and Imaging (775)
  • Rehabilitation Medicine and Physical Therapy (455)
  • Respiratory Medicine (623)
  • Rheumatology (274)
  • Sexual and Reproductive Health (225)
  • Sports Medicine (208)
  • Surgery (250)
  • Toxicology (43)
  • Transplantation (120)
  • Urology (94)